Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Becton Dickinson logoBecton Dickinson BDX

The company said it entered into definitive agreements with Waters Corporation on July 13, 2025 to combine its Biosciences and Diagnostic Solutions business with Waters in a Reverse Morris Trust transaction, and that it will receive about $4 billion in cash.

8-KEntry into a Material Definitive AgreementFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it entered into definitive agreements with Waters Corporation on July 13, 2025 to combine its Biosciences and Diagnostic Solutions business with Waters in a Reverse Morris Trust transaction, and that it will receive about $4 billion in cash.

  2. The company said that after the transaction, existing holders of SpinCo common stock will own 39.2% of Waters common stock on a fully diluted basis, and existing Waters shareholders will own 60.8%. It explained that the exchange ratio may be adjusted upward so that former company shareholders own at least 50.5% (the Tax Threshold) of Waters common stock for tax purposes.

  3. The company said SpinCo will pay the company $4 billion before the Spin-Off, and that this amount may be adjusted for SpinCo's cash, working capital and indebtedness. It also said financial institutions committed to provide a senior unsecured bridge loan facility to fund that payment.

  4. The company said either party may have termination rights if the merger is not completed on or before July 13, 2026, subject to extension for pending regulatory approvals. If the agreement is terminated under certain circumstances, Waters must pay the company a termination fee of $733 million.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Waters Reverse Morris Trust Transaction Structure

The company said it entered into definitive agreements with Waters Corporation on July 13, 2025 to combine its Biosciences and Diagnostic Solutions business with Waters in a Reverse Morris Trust transaction, and that it will receive about $4 billion in cash.

Source · Based on the filing body and exhibits

Becton Dickinson Shareholders to Hold 39.2% of Waters

The company said that after the transaction, existing holders of SpinCo common stock will own 39.2% of Waters common stock on a fully diluted basis, and existing Waters shareholders will own 60.8%. It explained that the exchange ratio may be adjusted upward so that former company shareholders own at least 50.5% (the Tax Threshold) of Waters common stock for tax purposes.

Source · Based on the filing body and exhibits

SpinCo's $4 billion Cash Distribution and Bridge Loan

The company said SpinCo will pay the company $4 billion before the Spin-Off, and that this amount may be adjusted for SpinCo's cash, working capital and indebtedness. It also said financial institutions committed to provide a senior unsecured bridge loan facility to fund that payment.

Source · Based on the filing body and exhibits

Outside Date and $733 million Termination Fee

The company said either party may have termination rights if the merger is not completed on or before July 13, 2026, subject to extension for pending regulatory approvals. If the agreement is terminated under certain circumstances, Waters must pay the company a termination fee of $733 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.